The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

被引：0
|
作者：
Uzma Khan
Helena Huerga
Aamir J. Khan
Carole D. Mitnick
Catherine Hewison
Francis Varaine
Mathieu Bastard
Michael Rich
Molly F. Franke
Sidney Atwood
Palwasha Y. Khan
Kwonjune J. Seung
机构：
[1] Interactive Research and Development (IRD),Field Epidemiology Department
[2] Epicentre,Department of Global Health and Social Medicine
[3] Interactive Research and Development (IRD) Global,Medical Department
[4] Harvard Medical School,Division of Global Health Equity
[5] Médecins Sans Frontières,undefined
[6] Partners In Health,undefined
[7] Brigham and Women’s Hospital,undefined
来源：
BMC Infectious Diseases | / 19卷
关键词：
MDR-TB; Bedaquiline; Delamanid; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
    Khan, Uzma
    Huerga, Helena
    Khan, Aamir J.
    Mitnick, Carole D.
    Hewison, Catherine
    Varaine, Francis
    Bastard, Mathieu
    Rich, Michael
    Franke, Molly F.
    Atwood, Sidney
    Khan, Palwasha Y.
    Seung, Kwonjune J.
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [2] Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
    Hewison, Catherine
    Khan, Uzma
    Bastard, Mathieu
    Lachenal, Nathalie
    Coutisson, Sylvine
    Osso, Elna
    Ahmed, Saman
    Khan, Palwasha
    Franke, Molly F.
    Rich, Michael L.
    Varaine, Francis
    Melikyan, Nara
    Seung, Kwonjune J.
    Adenov, Malik
    Adnan, Sana
    Danielyan, Narine
    Islam, Shirajul
    Janmohamed, Aleeza
    Karakozian, Hayk
    Kimenye, Maureen Kamene
    Kirakosyan, Ohanna
    Kholikulov, Begimkul
    Krisnanda, Aga
    Kumsa, Andargachew
    Leblanc, Garmaly
    Lecca, Leonid
    Nkuebe, Mpiti
    Mamsa, Shahid
    Padayachee, Shrivani
    Thit, Phone
    Mitnick, Carole D.
    Huerga, Helena
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (06) : 1006 - 1013
  • [3] Treatment outcome in patients with MDR-TB treated with bedaquiline containing regimens, Republic of Moldova
    Chesov, Dumitru
    Heyckendorf, Jan
    Reiman, Maja
    Alexandru, Sofia
    Donica, Ana
    Sov, Elena Che
    Crudu, Valeriu
    Botnaru, Victor
    Lange, Christoph
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort (vol 75, pg 1006, 2022)
    Campbell, B. N.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 779 - 779
  • [5] Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study
    Rodriguez, C. A.
    Brooks, M. B.
    Guglielmetti, L.
    Hewison, C.
    Jachym, M. F.
    Lessem, E.
    Varaine, F.
    Mitnick, C. D.
    PUBLIC HEALTH ACTION, 2019, 9 (01): : 32 - 41
  • [6] Bedaquiline-containing regimens for MDR TB treatment - Focus on the safety
    Borisov, Sergey
    Filippov, Alexsey
    Ivanushkina, Taisiya
    Ivanova, Diana
    Litvinova, Nataliya
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study
    Bonnet, M.
    Bastard, M.
    du Cros, P.
    Khamraev, A.
    Kimenye, K.
    Khurkhumal, S.
    Hayrapetyan, A.
    Themba, D.
    Telnov, A.
    Sanchez-Padilla, E.
    Hewison, C.
    Varaine, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (02) : 177 - 186
  • [8] Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial
    Cellamare, M.
    Milstein, M.
    Ventz, S.
    Baudin, E.
    Trippa, L.
    Mitnick, C. D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S8 - S12
  • [9] Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany
    Diel, Roland
    Hittel, Norbert
    Schaberg, Tom
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
    Koirala, S.
    Borisov, S.
    Danila, E.
    Mariandyshev, A.
    Shrestha, B.
    Lukhele, N.
    Dalcolmo, M.
    Shakya, S. R.
    Miliauskas, S.
    Kuksa, L.
    Manga, S.
    Aleksa, A.
    Denholm, J. T.
    Khadka, H. B.
    Skrahina, A.
    Diktanas, S.
    Ferrarese, M.
    Bruchfeld, J.
    Koleva, A.
    Piubello, A.
    Koirala, G. S.
    Udwadia, Z. F.
    Palmero, D. J.
    Munoz-Torrico, M.
    Gc, R.
    Gualano, G.
    Grecu, V., I
    Motta, I
    Papavasileiou, A.
    Li, Y.
    Hoefsloot, W.
    Kunst, H.
    Mazza-Stalder, J.
    Payen, M-C
    Akkerman, O. W.
    Bernal, E.
    Manfrin, V
    Matteelli, A.
    Hamdan, H. Mustafa
    Marcos, M. Nieto
    Cadinanos Loidi, J.
    Cebrian Gallardo, J. J.
    Duarte, R.
    Escobar Salinas, N.
    Gomez Rosso, R.
    Laniado-Laborin, R.
    Martinez Robles, E.
    Quiros Fernandez, S.
    Rendon, A.
    Solovic, I
    PULMONOLOGY, 2021, 27 (05): : 403 - 412
12345